JCM
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tzouvelekis, L. S.
Right arrow Articles by Legakis, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tzouvelekis, L. S.
Right arrow Articles by Legakis, N. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 1998, p. 266-268, Vol. 36, No. 1
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Sporadic Emergence of Klebsiella pneumoniae Strains Resistant to Cefepime and Cefpirome in Greek Hospitals

L. S. Tzouvelekis,1,* E. Tzelepi,1 E. Prinarakis,1 M. Gazouli,1 A. Katrahoura,2 P. Giakkoupi,1 O. Paniara,3 and N. J. Legakis4

Department of Bacteriology, Hellenic Pasteur Institute,1 Microbiology Laboratory, "Metaxa" Anticancer Hospital,2 Microbiology Laboratory, "Evagelismos" General Hospital,3 and Department of Microbiology, School of Medicine, Athens University,4 Athens, Greece

Received 8 May 1997/Returned for modification 3 September 1997/Accepted 2 October 1997

The sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome was observed in Greek hospitals during 1996. Examination of six epidemiologically distinct strains and clones selected in vitro provided indications that resistance is due to the cooperation of decreased outer membrane permeability and hydrolysis of the cephalosporins by SHV-5 beta -lactamase, which was produced in large amounts.


* Corresponding author. Mailing address: Department of Bacteriology, Hellenic Pasteur Institute, Vass. Sofias 127, Athens 11521, Greece. Phone: 0031-1-6462281. Fax: 0031-1-6423498. E-mail: LSTBACT{at}HOTMAIL.COM.


Journal of Clinical Microbiology, January 1998, p. 266-268, Vol. 36, No. 1
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1998 by the American Society for Microbiology. All rights reserved.